Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/26989
Title: | The site of breast cancer metastases dictates their clonal composition and reversible transcriptomic profile. | Austin Authors: | Berthelet, Jean;Wimmer, Verena C;Whitfield, Holly J;Serrano, Antonin;Boudier, Thomas;Mangiola, Stefano;Merdas, Michal;El-Saafin, Farrah;Baloyan, David;Wilcox, Jordan;Wilcox, Steven;Parslow, Adam C;Papenfuss, Anthony T;Yeo, Belinda ;Ernst, Matthias ;Pal, Bhupinder;Anderson, Robin L ;Davis, Melissa J;Rogers, Kelly L;Hollande, Frédéric;Merino, Delphine | Affiliation: | Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia Department of Medical Biology, Faculty of Medicine, Dentistry, and Health Science, The University of Melbourne, Parkville, VIC 3010, Australia Bioinformatics Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC 3000, Australia Olivia Newton-John Cancer Research Institute School of Cancer Medicine, La Trobe University, Bundoora, VIC 3086, Australia Austin Health Department of Clinical Pathology, Faculty of Medicine, Dentistry, and Health Science, The University of Melbourne, Melbourne, VIC 3000, Australia Advanced Technology and Biology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia University of Melbourne Centre for Cancer Research, Victorian Comprehensive Cancer Centre, Melbourne, VIC 3000, Australia |
Issue Date: | 2021 | Date: | 2021-07-07 | Publication information: | Science advances 2021; 7(28) | Abstract: | Intratumoral heterogeneity is a driver of breast cancer progression, but the nature of the clonal interactive network involved in this process remains unclear. Here, we optimized the use of optical barcoding to visualize and characterize 31 cancer subclones in vivo. By mapping the clonal composition of thousands of metastases in two clinically relevant sites, the lungs and liver, we found that metastases were highly polyclonal in lungs but not in the liver. Furthermore, the transcriptome of the subclones varied according to their metastatic niche. We also identified a reversible niche-driven signature that was conserved in lung and liver metastases collected during patient autopsies. Among this signature, we found that the tumor necrosis factor-α pathway was up-regulated in lung compared to liver metastases, and inhibition of this pathway affected metastasis diversity. These results highlight that the cellular and molecular heterogeneity observed in metastases is largely dictated by the tumor microenvironment. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/26989 | DOI: | 10.1126/sciadv.abf4408 | ORCID: | 0000-0003-2562-0575 0000-0002-9931-8179 0000-0002-7282-387X 0000-0002-8178-6441 0000-0002-0148-7733 0000-0001-7474-836X 0000-0003-3257-9953 0000-0002-1650-8007 0000-0002-0585-9573 0000-0002-9868-6914 0000-0002-1102-8506 0000-0002-9218-9917 0000-0003-4864-7033 0000-0002-6755-0221 0000-0002-7046-8392 0000-0002-8075-6275 |
Journal: | Science Advances | PubMed URL: | 34233875 | Type: | Journal Article |
Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.